<DOC>
	<DOCNO>NCT01500785</DOCNO>
	<brief_summary>Incomplete recovery ischemia cause stun myocardium . Ischemia may due coronary artery disease aortic cross-clamping surgery . Stunning lead myocardial dysfunction . It suggest mechanism responsible contractile depression stun myocardium decrease sensitivity myofibril calcium . Levosimendan calcium sensitizer , show improve function stun myocardium without obvious impairment diastolic function . Systemic vasodilation need vasoconstrictive medication usually apparent administration levosimendan . Colucci et al demonstrate intracoronary administration milrinone , another inodilator , systemic vasodilation could exclude . If true levosimendan , may possible improve leave ventricular hypo/dyskinesia without afterload reduction add levosimendan cardioplegia solution . The investigator hypotize levosimendan , deliver together cardioplegia , improve LV dysfunction open aortic cross-clamp patient undergoing aortic valve coronary artery bypass operation . Our primary endpoint change cardiac output 15 min separation cardiopulmonary bypass compare baseline . Secondary endpoint change LV ejection fraction baseline 5 min sternal closure cTnT/CK-MB first postoperative morning .</brief_summary>
	<brief_title>Intracoronary Administration Levosimendan Cardiac Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Myocardial Stunning</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>preoperative LVEF 40 % less septal wall thickness 11mm less moderate aortic insufficiency sinus rhythm CPB oesophageal disease know allergy levosimendan metabolites adjuvant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>